<DOC>
	<DOCNO>NCT01410929</DOCNO>
	<brief_summary>The objective post market clinical study collect prospective clinical data confirm efficacy RF Kyphoplasty treatment pathological fracture spine cause multiple myeloma .</brief_summary>
	<brief_title>Evaluation Vertebral Compression Fracture Fixation With RF Kyphoplasty Patients With Multiple Myeloma</brief_title>
	<detailed_description>Myeloma common primary cancer affect spine . Painful vertebral compression fracture ( VCFs ) affect approximately 30 % myeloma patient . As myeloma patient live longer , especially relevant provide best available treatment pain reduce disability result VCFs . Cement delivery well establish treatment method treat painful vertebra compromise tumor and/or osteoporosis . The StabiliT Vertebral Augmentation System ( DFine Inc. ) unique percutaneous vertebral augmentation system design provide physician mean create target cavity ultra-high viscosity cement ( use RF Energy ) deliver extended period time order allow control , target vertebral augmentation multiple myeloma patient .</detailed_description>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Fractures , Bone</mesh_term>
	<mesh_term>Fractures , Compression</mesh_term>
	<mesh_term>Spinal Fractures</mesh_term>
	<criteria>1 . Diagnosis multiple myeloma evidence myelomatous lesion spine , include plasmacytoma , lytic lesion fracture . 2 . One 6 painful ( pain palpation/percussion fracture vertebral body ) VCF ( ) , T3L5 , bone marrow edema image magnetic resonance imaging ( MRI ) ( Subjects 46 fracture treatment divide two session 1 7 day apart ) 3 . History fracture relate pain less ≤ 3 month old 4 . Pain VAS score ≥4 scale 0 10 . When subject newly diagnose multiple myeloma , pain assessment must do completion least one pulse steroid therapy one week initiation active multiple myeloma chemotherapy . Pain represent bad pain without use narcotic medication . 5 . Roland Morris Disability Questionnaire score ≥ 10 0 24 scale 6 . Subjects ≥ 21 year old . 7 . No change chemotherapy regimen ( change dose ( ) permit ) 1 month prior enrollment 8 . No change chemotherapy regimen ( change dose ( ) permit ) plan least 1 month follow enrollment 9 . Subject major surgery spine plan least 1 month follow enrollment 10 . Subject sufficient mental capacity comply protocol requirement 11 . Subject must willing able comply specify followup evaluation 12 . Subject understand potential risk benefit participate study willing provide write informed consent . 13 . Female subject must either longer capable reproduction take acceptable measure prevent pregnancy study 1 . Subjects primary tumor bone ( e.g. , osteosarcoma ) osteoblastic metastasis site index VCF . Subjects tumor anatomic site index VCF eligible . 2 . Subject concurrent Phase I investigational anticancer treatment 3 . Subject significant clinical morbidity ( aside index fracture ( ) cancer ) may potentially interfere collection data concern pain function 4 . Subject VCF morphology deem unsuitable RF Kyphoplasty ( e.g . vertebral planna ) 5 . Additional nonkyphoplasty surgical treatment require index fracture 6 . Subjects require use highdose steroid ( ≥ 100 mg prednisone 20 mg dexamethasone per day ) , intravenous ( IV ) pain medication , nerve block control chronic back pain unrelated index VCF ( ) . Subjects receive highdose steroid treatment cancer ( least 30 day ) eligible . 7 . Subjects platelet count &lt; 20,000 8 . Subject spinal cord compression significant canal compromise require decompression 9 . Subjects VCFs due osteoporosis 10 . Subject medical/surgical condition contrary kyphoplasty procedure ( e.g. , presence active incompletely treated local infection ) 11 . Positive baseline pregnancy test ( woman childbearing potential ) 12 . Subject neurologic deficit associate level ( ) treat severe radiculopathy ( e.g . myelopathy , cauda equina syndrome ) 13 . Subject segmental kyphosis &gt; 30° area treatment 14 . Subject uncontrolled coagulopathy 15 . Subject temporarily discontinue anticoagulation therapy 16 . Subject know allergy device material / PMMA 17 . Index VCF expose high energy trauma 18 . Subject severe cardiopulmonary deficiency contraindication local general anesthesia require procedure .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>multiple myeloma</keyword>
	<keyword>VCF</keyword>
	<keyword>Vertebral Compression Fracture</keyword>
	<keyword>Spine</keyword>
	<keyword>Kyphoplasty</keyword>
	<keyword>Back pain</keyword>
	<keyword>Cancer</keyword>
</DOC>